Schering-Plough Canada announces a $30.7 million expansion of its production plant in Pointe-Claire
"We are very pleased to have partnered with the Government of Québec on this important project," said
"We are pleased to work with great companies who have demonstrated a strong commitment to the
The expansion of the plant, which currently employs 330 people, is expected to create additional employment opportunities. Also, during construction, 150 workers will be employed full-time. Additionally, many of the materials needed for the expansion have been bought from local suppliers.
The production expansion will increase annual production to 35 million units. The Claritin Syrup brand, for example, will be produced in Pointe-Claire for the U.S. market. The Aerius brand will be manufactured at this plant for the entire Canadian market. The expanded plant will also produce liquids, creams and ointments for U.S. and Canadian markets.
Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.For further information: Erik de Pokomandy, GGA Communications/Public and Government Relations, (514) 393-9500 ext. 256, Mobile: (514) 242-5907, firstname.lastname@example.org; Kent Hovey-Smith, Schering-Plough Canada, (514) 428-7475, email@example.com